使用circRNAs作为癌症治疗的替代品的先进方法
Goran Sedeeq Hama Faraj1, Bashdar Mahmud Hussen2,3, Snur Rasool Abdullah4
1Department of Medical Laboratory Science, Komar University of Science and Technology, Sulaymaniyah, 46001, Iraq.
Non-coding RNA research
|April 9, 2024
概括
循环RNAs (circRNAs) 由于其稳定性,显示出作为新型癌症疗法的前景. 克服当前的挑战是推动基于circRNA的治疗以改善癌症护理的关键.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 癌症仍然是一个复杂的全球卫生挑战,尽管精密医学和免疫治疗的进步.
- 非编码RNAs,特别是循环RNAs (circRNAs),越来越多地被认为对癌症发育和进展的作用.
- 由于其独特的结构和稳定性,circRNAs具有作为诊断标记物和治疗点的潜力.
研究的目的:
- 探索circRNAs作为癌症治疗的新治疗策略的潜力.
- 确定和讨论阻碍基于circRNA的癌症疗法的临床应用的主要挑战.
- 提出克服这些挑战和推进circRNA治疗的策略.
主要方法:
- 文献综述和对癌症中circRNAs最近研究的分析.
- 探索circRNAs的生物功能和治疗潜力.
- 讨论现有挑战和针对基于circRNA的疗法开发提出的解决方案.
主要成果:
- circRNAs具有独特的结构和稳定性特征,使其成为癌症治疗的有希望的候选人.
- 在应用circRNAs用于癌症治疗方面存在重大挑战,包括传递和特异性.
- 克服这些障碍的策略对于实现circRNAs的全部治疗潜力至关重要.
结论:
- circRNAs代表了创新的癌症治疗的前沿.
- 解决circRNA技术当前的局限性对于成功的临床转化至关重要.
- 进一步的研究和战略开发可以带来先进的,长期有效的基于circRNA的癌症治疗.
相关概念视频
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
02:30siRNA - Small Interfering RNAs
16.7K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.7K
02:39lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
02:15Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
01:22MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K